{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:55:36Z","timestamp":1759056936558},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Council of Science and Technology of Mexico (CONACYT)","award":["57204"],"award-info":[{"award-number":["57204"]}]},{"name":"Anahuac University"},{"name":"Camina Research Center"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.neulet.2013.08.048","type":"journal-article","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T01:47:01Z","timestamp":1378345621000},"page":"59-63","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Prophylactic neuroprotection with A91 improves the outcome of spinal cord injured rats"],"prefix":"10.1016","volume":"554","author":[{"given":"A.","family":"Ibarra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Mestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Marti\u00f1\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.A.","family":"Pineda-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Guti\u00e9rrez-Ospina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2013.08.048_bib0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00402-004-0763-5","article-title":"Iatrogenic paraplegia in spinal surgery","volume":"125","author":"Delank","year":"2005","journal-title":"Arch. Orthop. Trauma Surg."},{"key":"10.1016\/j.neulet.2013.08.048_bib0010","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/sc.2011.72","article-title":"Iatrogenic spinal cord injury: an observational study","volume":"49","author":"Alcanyis-Alberola","year":"2011","journal-title":"Spinal Cord"},{"key":"10.1016\/j.neulet.2013.08.048_bib0015","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3109\/00207454.2012.700660","article-title":"Risk factors of iatrogenic spinal cord injury in spinal surgery: a multicenter retrospective study","volume":"122","author":"Chen","year":"2012","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.neulet.2013.08.048_bib0020","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/sc.2008.85","article-title":"Lack of neuroprotection with pharmacological pretreatment in a paradigm for anticipated spinal cord lesions","volume":"47","author":"Guizar-Sahagun","year":"2009","journal-title":"Spinal Cord"},{"key":"10.1016\/j.neulet.2013.08.048_bib0025","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1172\/JCI12837","article-title":"Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease","volume":"108","author":"Hauben","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neulet.2013.08.048_bib0030","doi-asserted-by":"crossref","first-page":"13174","DOI":"10.1073\/pnas.0603747103","article-title":"Synergy between immune cells and adult neural stem\/progenitor cells promotes functional recovery from spinal cord injury","volume":"103","author":"Ziv","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.neulet.2013.08.048_bib0035","doi-asserted-by":"crossref","first-page":"e32027","DOI":"10.1371\/journal.pone.0032027","article-title":"Development of protective autoimmunity by immunization with a neural-derived peptide is ineffective in severe spinal cord injury","volume":"7","author":"Martinon","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neulet.2013.08.048_bib0040","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neulet.2010.04.003","article-title":"Immunization with neural-derived antigens inhibits lipid peroxidation after spinal cord injury","volume":"476","author":"Ibarra","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2013.08.048_bib0045","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/jnr.22771","article-title":"Immunization with A91 peptide or copolymer-1 reduces the production of nitric oxide and inducible nitric oxide synthase gene expression after spinal cord injury","volume":"90","author":"Garcia","year":"2012","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neulet.2013.08.048_bib0050","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/bcpt.12023","article-title":"Therapeutic window for combination therapy of A91 peptide and glutathione allows delayed treatment after spinal cord injury","volume":"112","author":"Del Rayo","year":"2013","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.neulet.2013.08.048_bib0055","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1111\/j.0953-816X.2004.03402.x","article-title":"The therapeutic window after spinal cord injury can accommodate T cell-based vaccination and methylprednisolone in rats","volume":"19","author":"Ibarra","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neulet.2013.08.048_bib0060","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1460-9568.2007.05650.x","article-title":"Vaccination with a neural-derived peptide plus administration of glutathione improves the performance of paraplegic rats","volume":"26","author":"Martinon","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neulet.2013.08.048_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/neu.1995.12.1","article-title":"A sensitive and reliable locomotor rating scale for open field testing in rats","volume":"12","author":"Basso","year":"1995","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.neulet.2013.08.048_bib0070","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1046\/j.1460-9568.1998.00100.x","article-title":"Basic and acidic fibroblast growth factors protect spinal motor neurones in vivo after experimental spinal cord injury","volume":"10","author":"Teng","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neulet.2013.08.048_bib0075","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1471-4159.2004.02954.x","article-title":"Protective autoimmunity: interferon-gamma enables microglia to remove glutamate without evoking inflammatory mediators","volume":"92","author":"Shaked","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2013.08.048_bib0080","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1523\/JNEUROSCI.22-07-02690.2002","article-title":"Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy","volume":"22","author":"Jones","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2013.08.048_bib0085","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0006-8993(03)02898-1","article-title":"Effects of cyclosporin-A on immune response, tissue protection and motor function of rats subjected to spinal cord injury","volume":"979","author":"Ibarra","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2013.08.048_bib0090","doi-asserted-by":"crossref","first-page":"15173","DOI":"10.1073\/pnas.011585298","article-title":"Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens","volume":"98","author":"Hauben","year":"2001","journal-title":"PNAS"},{"key":"10.1016\/j.neulet.2013.08.048_bib0095","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1523\/JNEUROSCI.20-17-06421.2000","article-title":"Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion","volume":"20","author":"Hauben","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2013.08.048_bib0100","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0140-6736(99)05140-5","article-title":"Autoimmune T cells as potential neuroprotective therapy for spinal cord injury","volume":"355","author":"Hauben","year":"2000","journal-title":"Lancet"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394013007817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394013007817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T09:55:48Z","timestamp":1563875748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394013007817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":20,"alternative-id":["S0304394013007817"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2013.08.048","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic neuroprotection with A91 improves the outcome of spinal cord injured rats","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2013.08.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}